University of California, San Francisco
San Francisco, California, United States
141 recruiting
Showing 1–20 of 141 trials
Recruiting
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research4,500 enrolled50 locationsNCT04477785
Recruiting
Phase 3
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Verastem, Inc.270 enrolled106 locationsNCT06072781
Recruiting
Phase 2
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Allogene Therapeutics250 enrolled61 locationsNCT06500273
Recruiting
Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Central Nervous System TumorGlioblastomaCNS Tumor+5 more
Sabine Mueller, MD, PhD208 enrolled6 locationsNCT04732065
Recruiting
Mechanisms of Resistance to PSMA Radioligand Therapy
Prostate Cancer
University of California, San Francisco125 enrolled3 locationsNCT05435495
Recruiting
Prospective Registry of Histotripsy for Soft Tissue Tumors
Soft Tissue NeoplasmSoft Tissue CancerSoft Tissue Lesion
University of California, San Francisco200 enrolled1 locationNCT07470008
Recruiting
Not Applicable
CONNECTing to LungCare
Lung CarcinomaSmoking CessationCigarette Smoking-Related Carcinoma
University of California, San Francisco147 enrolled1 locationNCT06213532
Recruiting
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Metastatic Breast CancerLobular Breast Carcinoma
University of California, San Francisco12 enrolled4 locationsNCT05964504
Recruiting
Phase 1Phase 2
64Cu-GRIP B in Patients With Advanced Malignancies
Prostate CancerAdvanced Solid TumorSolid Tumor, Adult+3 more
Rahul Aggarwal91 enrolled1 locationNCT05888532
Recruiting
Phase 2
Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
AngiosarcomaAngiosarcoma, Adult
Varun Monga, MBBS18 enrolled1 locationNCT06898970
Recruiting
Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+6 more
Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022
Recruiting
Not Applicable
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
MedulloblastomaEpendymomaEpendymoma of Brain+3 more
University of California, San Francisco74 enrolled8 locationsNCT05057702
Recruiting
Phase 1
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
Pediatric Brain TumorRecurrent Pediatric Brain TumorPediatric Neoplasm
Sabine Mueller, MD, PhD24 enrolled8 locationsNCT05887882
Recruiting
Phase 1
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
GlioblastomaEGFR Gene MutationMGMT-Unmethylated Glioblastoma+1 more
Hideho Okada, MD, PhD20 enrolled1 locationNCT06186401
Recruiting
Not Applicable
Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
Behavioral InterventionViral Suppression of HIV InfectionART Adherence
University of California, San Francisco270 enrolled1 locationNCT07125235
Recruiting
Phase 2
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Novo Nordisk A/S200 enrolled109 locationsNCT06979362
Recruiting
Not Applicable
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Heart Failure With Preserved Ejection Fraction (HFpEF)
Axon Therapies, Inc.150 enrolled20 locationsNCT04592445
Recruiting
Not Applicable
Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis (AIS)
University of California, San Francisco64 enrolled1 locationNCT06365892
Recruiting
Not Applicable
Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release
HIV (Human Immunodeficiency Virus)
University of California, San Francisco33 enrolled1 locationNCT07115901
Recruiting
Phase 1
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
Multiple MyelomaRefractory Multiple MyelomaRecurrent Multiple Myeloma
Thomas Martin, MD30 enrolled1 locationNCT07340853